The Best Risk-To-Reward COVID-19 Treatment Plays

While both of these companies are likely to benefit in the coming years from their respective COVID-19 treatments, neither is dependent on the success of those products for their stocks to move higher. As a result, they may be two of the most compelling COVID-19 treatment plays from a risk-to-reward perspective. CLICK HERE.